Statin Use Associated With a Decreased Risk of Community-Acquired Staphylococcus aureus Bacteremia/In Reply
Interestingly, a recent study by Plotkin and Konakieva3 found that steroid hormones with the 3-hydroxy moiety (eg, cholesterol and estradiol) increased carotenoid levels in S aureus, which potentially increases bacterial virulence.4 Patients with chronic kidney disease usually have low levels of sex...
Gespeichert in:
Veröffentlicht in: | Mayo Clinic proceedings 2018-04, Vol.93 (4), p.541-542 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 542 |
---|---|
container_issue | 4 |
container_start_page | 541 |
container_title | Mayo Clinic proceedings |
container_volume | 93 |
creator | Ko, Humphrey H T Lareu, Ricky R Dix, Brett R Hughes, Jeffery D Smit, Jesper Schønheyder, Henrik Carl Nielsen, Henrik Søgaard, Mette López-Cortés, Luis Eduardo Rodríguez-Baño, Jesús Thomsen, Reimar Wernich Frøslev, Trine |
description | Interestingly, a recent study by Plotkin and Konakieva3 found that steroid hormones with the 3-hydroxy moiety (eg, cholesterol and estradiol) increased carotenoid levels in S aureus, which potentially increases bacterial virulence.4 Patients with chronic kidney disease usually have low levels of sex steroid hormones,5 but high levels of estradiol may present in septic patients.6 Knowledge of the antibiotic treatment outcomes for patients with chronic kidney who have CA-SAB and are statin users, compared with nonusers, might provide clues as to whether statins could offer additional benefits by suppressing the antagonistic precursor cholesterol molecule and downstream steroidal hormones sufficiently, resulting in efficacious antibiotic therapy. Because statins may induce newonset diabetes and the colonization of skin and mucosae with S aureus predisposes diabetic patients to infections,7,8 statin users with diabetes might be expected to have a higher risk of CASAB. Howe K, Sanat F, Thumser AE, Coleman T, Plant N. The statin class of HMG-CoA reductase inhibitors demonstrate differential activation of the nuclear receptors PXR, CAR and FXR, as well as their downstream target genes. Xenobiotica. 2011;41(7):519-529. https://doi.org/10.1016/j.mayocp.2017.12.024 In Reply-Statin Use Associated With a Decreased Risk of Community-Acquired Staphylococcus aureus Bacteremia We appreciate Dr Ko and colleagues' interesting reflections on our findings concerning the influence of statin use on the risk of communityacquired Staphylococcus aureus bacteremia (CA-SAB). Because the aim of our study was to provide epidemiological in vivo data on this association, Ko and colleagues' review of the literature and considerations on the potential underlying pathophysiologic mechanisms constitute a very valuable supplement to our paper. |
format | Article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_2049975791</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2049975791</sourcerecordid><originalsourceid>FETCH-proquest_journals_20499757913</originalsourceid><addsrcrecordid>eNqNjDkOwjAQRV2ARFjuMBJ1hAmEyGXYBC2LKJFlJsLZHDx2kdvjggNQPem_pz9gEedJGm-WYjNiY6KSc54JsY5YdXXS6RbuhJATGaWlwxc8tHuDhD0qi5LCcNFUgSlgZ5rGt9r1ca4-XtugwkP37mujjFKeQHqLAVupHFpstFycW7hgV_dTNixkTTj7ccLmx8Ntd4o7az4eyT1L420b1DPhayGyNBPL1X_VF430SD8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2049975791</pqid></control><display><type>article</type><title>Statin Use Associated With a Decreased Risk of Community-Acquired Staphylococcus aureus Bacteremia/In Reply</title><source>ProQuest Central UK/Ireland</source><source>Alma/SFX Local Collection</source><creator>Ko, Humphrey H T ; Lareu, Ricky R ; Dix, Brett R ; Hughes, Jeffery D ; Smit, Jesper ; Schønheyder, Henrik Carl ; Nielsen, Henrik ; Søgaard, Mette ; López-Cortés, Luis Eduardo ; Rodríguez-Baño, Jesús ; Thomsen, Reimar Wernich ; Frøslev, Trine</creator><creatorcontrib>Ko, Humphrey H T ; Lareu, Ricky R ; Dix, Brett R ; Hughes, Jeffery D ; Smit, Jesper ; Schønheyder, Henrik Carl ; Nielsen, Henrik ; Søgaard, Mette ; López-Cortés, Luis Eduardo ; Rodríguez-Baño, Jesús ; Thomsen, Reimar Wernich ; Frøslev, Trine</creatorcontrib><description>Interestingly, a recent study by Plotkin and Konakieva3 found that steroid hormones with the 3-hydroxy moiety (eg, cholesterol and estradiol) increased carotenoid levels in S aureus, which potentially increases bacterial virulence.4 Patients with chronic kidney disease usually have low levels of sex steroid hormones,5 but high levels of estradiol may present in septic patients.6 Knowledge of the antibiotic treatment outcomes for patients with chronic kidney who have CA-SAB and are statin users, compared with nonusers, might provide clues as to whether statins could offer additional benefits by suppressing the antagonistic precursor cholesterol molecule and downstream steroidal hormones sufficiently, resulting in efficacious antibiotic therapy. Because statins may induce newonset diabetes and the colonization of skin and mucosae with S aureus predisposes diabetic patients to infections,7,8 statin users with diabetes might be expected to have a higher risk of CASAB. Howe K, Sanat F, Thumser AE, Coleman T, Plant N. The statin class of HMG-CoA reductase inhibitors demonstrate differential activation of the nuclear receptors PXR, CAR and FXR, as well as their downstream target genes. Xenobiotica. 2011;41(7):519-529. https://doi.org/10.1016/j.mayocp.2017.12.024 In Reply-Statin Use Associated With a Decreased Risk of Community-Acquired Staphylococcus aureus Bacteremia We appreciate Dr Ko and colleagues' interesting reflections on our findings concerning the influence of statin use on the risk of communityacquired Staphylococcus aureus bacteremia (CA-SAB). Because the aim of our study was to provide epidemiological in vivo data on this association, Ko and colleagues' review of the literature and considerations on the potential underlying pathophysiologic mechanisms constitute a very valuable supplement to our paper.</description><identifier>ISSN: 0025-6196</identifier><language>eng</language><publisher>Rochester: Elsevier Limited</publisher><subject>Antibiotics ; Antimicrobial agents ; Bacteremia ; Diabetes ; Hormones ; Infections ; Kidney diseases ; Mortality ; Neutrophils ; Sepsis ; Staphylococcus aureus ; Statins ; Systematic review</subject><ispartof>Mayo Clinic proceedings, 2018-04, Vol.93 (4), p.541-542</ispartof><rights>Copyright Mayo Foundation for Medical Education and Research Apr 2018</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2049975791?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,64385,64389,72469</link.rule.ids></links><search><creatorcontrib>Ko, Humphrey H T</creatorcontrib><creatorcontrib>Lareu, Ricky R</creatorcontrib><creatorcontrib>Dix, Brett R</creatorcontrib><creatorcontrib>Hughes, Jeffery D</creatorcontrib><creatorcontrib>Smit, Jesper</creatorcontrib><creatorcontrib>Schønheyder, Henrik Carl</creatorcontrib><creatorcontrib>Nielsen, Henrik</creatorcontrib><creatorcontrib>Søgaard, Mette</creatorcontrib><creatorcontrib>López-Cortés, Luis Eduardo</creatorcontrib><creatorcontrib>Rodríguez-Baño, Jesús</creatorcontrib><creatorcontrib>Thomsen, Reimar Wernich</creatorcontrib><creatorcontrib>Frøslev, Trine</creatorcontrib><title>Statin Use Associated With a Decreased Risk of Community-Acquired Staphylococcus aureus Bacteremia/In Reply</title><title>Mayo Clinic proceedings</title><description>Interestingly, a recent study by Plotkin and Konakieva3 found that steroid hormones with the 3-hydroxy moiety (eg, cholesterol and estradiol) increased carotenoid levels in S aureus, which potentially increases bacterial virulence.4 Patients with chronic kidney disease usually have low levels of sex steroid hormones,5 but high levels of estradiol may present in septic patients.6 Knowledge of the antibiotic treatment outcomes for patients with chronic kidney who have CA-SAB and are statin users, compared with nonusers, might provide clues as to whether statins could offer additional benefits by suppressing the antagonistic precursor cholesterol molecule and downstream steroidal hormones sufficiently, resulting in efficacious antibiotic therapy. Because statins may induce newonset diabetes and the colonization of skin and mucosae with S aureus predisposes diabetic patients to infections,7,8 statin users with diabetes might be expected to have a higher risk of CASAB. Howe K, Sanat F, Thumser AE, Coleman T, Plant N. The statin class of HMG-CoA reductase inhibitors demonstrate differential activation of the nuclear receptors PXR, CAR and FXR, as well as their downstream target genes. Xenobiotica. 2011;41(7):519-529. https://doi.org/10.1016/j.mayocp.2017.12.024 In Reply-Statin Use Associated With a Decreased Risk of Community-Acquired Staphylococcus aureus Bacteremia We appreciate Dr Ko and colleagues' interesting reflections on our findings concerning the influence of statin use on the risk of communityacquired Staphylococcus aureus bacteremia (CA-SAB). Because the aim of our study was to provide epidemiological in vivo data on this association, Ko and colleagues' review of the literature and considerations on the potential underlying pathophysiologic mechanisms constitute a very valuable supplement to our paper.</description><subject>Antibiotics</subject><subject>Antimicrobial agents</subject><subject>Bacteremia</subject><subject>Diabetes</subject><subject>Hormones</subject><subject>Infections</subject><subject>Kidney diseases</subject><subject>Mortality</subject><subject>Neutrophils</subject><subject>Sepsis</subject><subject>Staphylococcus aureus</subject><subject>Statins</subject><subject>Systematic review</subject><issn>0025-6196</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNjDkOwjAQRV2ARFjuMBJ1hAmEyGXYBC2LKJFlJsLZHDx2kdvjggNQPem_pz9gEedJGm-WYjNiY6KSc54JsY5YdXXS6RbuhJATGaWlwxc8tHuDhD0qi5LCcNFUgSlgZ5rGt9r1ca4-XtugwkP37mujjFKeQHqLAVupHFpstFycW7hgV_dTNixkTTj7ccLmx8Ntd4o7az4eyT1L420b1DPhayGyNBPL1X_VF430SD8</recordid><startdate>20180401</startdate><enddate>20180401</enddate><creator>Ko, Humphrey H T</creator><creator>Lareu, Ricky R</creator><creator>Dix, Brett R</creator><creator>Hughes, Jeffery D</creator><creator>Smit, Jesper</creator><creator>Schønheyder, Henrik Carl</creator><creator>Nielsen, Henrik</creator><creator>Søgaard, Mette</creator><creator>López-Cortés, Luis Eduardo</creator><creator>Rodríguez-Baño, Jesús</creator><creator>Thomsen, Reimar Wernich</creator><creator>Frøslev, Trine</creator><general>Elsevier Limited</general><scope>3V.</scope><scope>4U-</scope><scope>7RV</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope></search><sort><creationdate>20180401</creationdate><title>Statin Use Associated With a Decreased Risk of Community-Acquired Staphylococcus aureus Bacteremia/In Reply</title><author>Ko, Humphrey H T ; Lareu, Ricky R ; Dix, Brett R ; Hughes, Jeffery D ; Smit, Jesper ; Schønheyder, Henrik Carl ; Nielsen, Henrik ; Søgaard, Mette ; López-Cortés, Luis Eduardo ; Rodríguez-Baño, Jesús ; Thomsen, Reimar Wernich ; Frøslev, Trine</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_20499757913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Antibiotics</topic><topic>Antimicrobial agents</topic><topic>Bacteremia</topic><topic>Diabetes</topic><topic>Hormones</topic><topic>Infections</topic><topic>Kidney diseases</topic><topic>Mortality</topic><topic>Neutrophils</topic><topic>Sepsis</topic><topic>Staphylococcus aureus</topic><topic>Statins</topic><topic>Systematic review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ko, Humphrey H T</creatorcontrib><creatorcontrib>Lareu, Ricky R</creatorcontrib><creatorcontrib>Dix, Brett R</creatorcontrib><creatorcontrib>Hughes, Jeffery D</creatorcontrib><creatorcontrib>Smit, Jesper</creatorcontrib><creatorcontrib>Schønheyder, Henrik Carl</creatorcontrib><creatorcontrib>Nielsen, Henrik</creatorcontrib><creatorcontrib>Søgaard, Mette</creatorcontrib><creatorcontrib>López-Cortés, Luis Eduardo</creatorcontrib><creatorcontrib>Rodríguez-Baño, Jesús</creatorcontrib><creatorcontrib>Thomsen, Reimar Wernich</creatorcontrib><creatorcontrib>Frøslev, Trine</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>University Readers</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Immunology Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Science Journals</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><jtitle>Mayo Clinic proceedings</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ko, Humphrey H T</au><au>Lareu, Ricky R</au><au>Dix, Brett R</au><au>Hughes, Jeffery D</au><au>Smit, Jesper</au><au>Schønheyder, Henrik Carl</au><au>Nielsen, Henrik</au><au>Søgaard, Mette</au><au>López-Cortés, Luis Eduardo</au><au>Rodríguez-Baño, Jesús</au><au>Thomsen, Reimar Wernich</au><au>Frøslev, Trine</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Statin Use Associated With a Decreased Risk of Community-Acquired Staphylococcus aureus Bacteremia/In Reply</atitle><jtitle>Mayo Clinic proceedings</jtitle><date>2018-04-01</date><risdate>2018</risdate><volume>93</volume><issue>4</issue><spage>541</spage><epage>542</epage><pages>541-542</pages><issn>0025-6196</issn><abstract>Interestingly, a recent study by Plotkin and Konakieva3 found that steroid hormones with the 3-hydroxy moiety (eg, cholesterol and estradiol) increased carotenoid levels in S aureus, which potentially increases bacterial virulence.4 Patients with chronic kidney disease usually have low levels of sex steroid hormones,5 but high levels of estradiol may present in septic patients.6 Knowledge of the antibiotic treatment outcomes for patients with chronic kidney who have CA-SAB and are statin users, compared with nonusers, might provide clues as to whether statins could offer additional benefits by suppressing the antagonistic precursor cholesterol molecule and downstream steroidal hormones sufficiently, resulting in efficacious antibiotic therapy. Because statins may induce newonset diabetes and the colonization of skin and mucosae with S aureus predisposes diabetic patients to infections,7,8 statin users with diabetes might be expected to have a higher risk of CASAB. Howe K, Sanat F, Thumser AE, Coleman T, Plant N. The statin class of HMG-CoA reductase inhibitors demonstrate differential activation of the nuclear receptors PXR, CAR and FXR, as well as their downstream target genes. Xenobiotica. 2011;41(7):519-529. https://doi.org/10.1016/j.mayocp.2017.12.024 In Reply-Statin Use Associated With a Decreased Risk of Community-Acquired Staphylococcus aureus Bacteremia We appreciate Dr Ko and colleagues' interesting reflections on our findings concerning the influence of statin use on the risk of communityacquired Staphylococcus aureus bacteremia (CA-SAB). Because the aim of our study was to provide epidemiological in vivo data on this association, Ko and colleagues' review of the literature and considerations on the potential underlying pathophysiologic mechanisms constitute a very valuable supplement to our paper.</abstract><cop>Rochester</cop><pub>Elsevier Limited</pub></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0025-6196 |
ispartof | Mayo Clinic proceedings, 2018-04, Vol.93 (4), p.541-542 |
issn | 0025-6196 |
language | eng |
recordid | cdi_proquest_journals_2049975791 |
source | ProQuest Central UK/Ireland; Alma/SFX Local Collection |
subjects | Antibiotics Antimicrobial agents Bacteremia Diabetes Hormones Infections Kidney diseases Mortality Neutrophils Sepsis Staphylococcus aureus Statins Systematic review |
title | Statin Use Associated With a Decreased Risk of Community-Acquired Staphylococcus aureus Bacteremia/In Reply |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T14%3A05%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Statin%20Use%20Associated%20With%20a%20Decreased%20Risk%20of%20Community-Acquired%20Staphylococcus%20aureus%20Bacteremia/In%20Reply&rft.jtitle=Mayo%20Clinic%20proceedings&rft.au=Ko,%20Humphrey%20H%20T&rft.date=2018-04-01&rft.volume=93&rft.issue=4&rft.spage=541&rft.epage=542&rft.pages=541-542&rft.issn=0025-6196&rft_id=info:doi/&rft_dat=%3Cproquest%3E2049975791%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2049975791&rft_id=info:pmid/&rfr_iscdi=true |